AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)
AAPL 167.3 +3.34 (+2.04%)MSFT 104.11 +1.23 (+1.20%)FB 145.75 +5.44 (+3.88%)ZNGA 3.73 0 (+0.13%)NVDA 150.2 +6.7 (+4.67%)WBA 76.32 +0.25 (+0.34%)GOOG 1045.03 +27.51 (+2.70%)PIH 4.26 -0.74 (-14.80%)

Balance Sheet ABEO Quote Abeona Ther

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 40 69 138
ShortTermInvest 0 0 0
Cash 40 69 138
AccountReceivab 0 0 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 41 69 141
PPE 0 1 2
AccumulatedDepr 0 0 0
NetPPE 0 1 1
EquityAndOtherI 0 0 0
Goodwill 32 32 32
IntangibleAsset 7 8 4
OtherLTAssets 0 0 0
TotalNonCurrent 39 42 38
TotalAssets 80 111 179
ShortTermDebt 0 0 0
AccountsPayable 1 4 2
TaxesPayable 0 0 0
AccruedLiabilit 0 0 0
DeferredRevenue 1 1 3
OtherCurrentLia 0 4 0
TotalCurrentLia 1 8 6
Debt 0 0 0
DeferredTaxesLi 0 0 0
DeferredRevenue 4 4 3
OtherLTLiabilit 7 0 0
TotalNonCurrent 11 4 3
TotalLiabilitie 12 12 9
CommonStock 0 0 0
AdditionalPaidI 378 431 529
RetainedEarning -311 -332 -360
AccumulatedOthe 0 0 0
TotalStockholde 68 99 170
TotalLiabilitie 80 111 179
Abeona Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abeona Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.